'Voordelen AstraZeneca veel groter dan de nadelen' 5 vragen aan immunoloog Marjolein van
Marjolein van Egmond PROF.DR. Full Professor, AII - Cancer immunology Full Professor, AII - Inflammatory diseases Full Professor, CCA - Cancer biology and immunology Full Professor, Molecular cell biology and Immunology Full Professor, Surgery PI 2004 2023 Specialization Immunotherapy, cancer, inflammatory diseases, antibodies, immunology
Onderzoeker van de week Marjolein van Egmond KWF Kankerbestrijding
Mandy Gruijs 1 , Celine A N Sewnath 1 , Marjolein van Egmond 2 Affiliations 1 Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Molecular Cell Biology and Immunology, Cancer Center Amsterdam - Amsterdam Institute for Infection and Immunity, De Boelelaan 1117, Amsterdam, the Netherlands.
Marjolein VAN EGMOND PHD PhD Thomas More University of Applied Sciences, Geel Logopedie en
Marjolein van Egmond is professor in Oncology and Inflammation. She is PI at the Department of Molecular Cell Biology & Immunology and staff member at the Department of Surgery. Throughout her career she has been fascinated by the role of antibodies in immunity and the activation of immune cells via antibody receptors (Fc receptors).
Kennislink interviewt Marjolein van Egmond over de taal van afasiepatiënten Nieuws
2013: Wim van Egmond — This is the 40th year that camera maker Nikon has held its Small World competition, which seeks the best magnified images melding science and art.
'Dat was de mooiste dag van m’n leven' KIJK Magazine
Marjolein van Egmond professor of immunology at Amsterdam UMC and epidemiologist Susan van den Hof of RIVM were interviewed about this topic by Trouw. Isn't it time for another round of vaccinations? The RIVM's so-called response team closely examines this question, explains epidemiologist Susan van den Hof, who works at the institute..
Coronavaccins en mutaties van het virus. Prof. Marjolein van Egmond legt uit. YouTube
Marjolein van Egmond Amsterdam University Medical Center | VUmc · Cancer Center Amsterdam (VUmc CCA) Connect with experts in your field Join ResearchGate to contact this researcher and connect.
Prof. dr. Marjolein van Egmond adresses public concerns and rumours about COVID19 and vaccines
Marjolein van Egmond Inflammation and cancer Innate myeloid cells, such as monocytes, macrophages and granulocytes (neutrophils), play an important role in host defence against pathogens as well as tumour cells. Our research group focuses on the diverse functions of macrophages and neutrophils, which are also referred to as inflammatory cells.
Marjolein van Egmond legt uit dit moeten zwangeren weten over corona LINDA.nl
For the series Onderwater Ondervraagt, Laurien Onderwater interviews Dutch scientists. In January 2023, it was the turn of our Marjolein van Egmond, immunologist at Amsterdam UMC. The article elaborates on Prof. Van Egmond's research in which she focuses on antibodies and their role in autoimmune diseases and cancer.
Immunoloog Marjolein van Egmond over het vaccineren van twaalf tot vijftienjarigen Op1 YouTube
Marjolein van Egmond Group members Amélie Bos (PhD student) Patients with inflammatory bowel disease (IBD) are characterized by the presence of auto-antibodies. However, the role of these auto-antibodies within pathology remains unclear.
MARJOLEIN VAN EGMOND VUmc Cancer Center Amsterdam (VUmc CCA)
Marjolein van Egmond 30984170 PMC6448004 10.3389/fimmu.2019.00553 Immunoglobulin A (IgA) is the most abundant antibody class present at mucosal surfaces. The production of IgA exceeds the production of all other antibodies combined, supporting its prominent role in host-pathogen defense.
Marjolein van Egmond over een mogelijke derde prik Op1
Prof.dr. Marjolein van Egmond received her Ph.D. from University Medical Center Utrecht, The Netherlands in 2000 (under supervision of Prof. Dr. J.G.J. van de Winkel). Her thesis focussed on the identification the function of the human Fc receptor for immunoglobulin A (FcαRI). Since FcαRI was identified as potential target for tumour therapy, the focus of the research shifted during a short.
Immunologe Marjolein van Egmond over het laatste vaccinatie nieuws Op1
Marjolein van Egmond and Timo K. van den Berg authors contributed equally to this study. This article is part of a series of reviews covering Neutrophils and Friends appearing in Volume 314 of Immunological Reviews .
Marjolein van Egmond met goed nieuws over het vaccin van Janssen uit Leiden Op1
Recently Marjolein van Egmond, professor in Oncology and Inflammation, has been granted the 2022 DSI honorary member status and received the Jon van Rood medal.
Coronavaccins waarom je laten vaccineren als je gezond bent? Prof. Marjolein van Egmond legt
Zorg Uw artsen en zorgverleners Prof. Marjolein van Egmond Prof. Marjolein van Egmond Meer Wetenschapper, vakgebied Oncologie en Ontsteking Contact Deze arts heeft (nog) geen informatie aangeleverd. AMC en VUmc zijn al een tijdje samen Amsterdam UMC.
Prof. dr. Marjolein van Egmond adresses public concerns and rumours about COVID19 and vaccines
Marjolein van Egmond is professor in Oncology and Inflammation. She is PI at the Department of Molecular Cell Biology & Immunology and staff member at the Department of Surgery. Throughout her career she has been fascinated by the role of antibodies in immunity and the activation of immune cells via antibody receptors (Fc receptors).
Coronavaccins de veiligheid. Prof. Marjolein van Egmond legt uit. YouTube
Marjolein van Egmond 1 Affiliation 1 VU University Medical Center, Departments of Surgical Oncology, and Molecular Cell Biology and Immunology, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands. [email protected]; PMID: 18081538 DOI: 10.1517.